Auron Therapeutics, Inc.
Auron Therapeutics is a privately held patient-centered, platform-powered, product-driven oncology company. We are the leaders in identifying and targeting cell state to treat a range of solid tumors and hematological malignancies.
Auron Therapeutics, Inc.
Auron Therapeutics is a clinical-stage biotechnology company focused on developing targeted cancer therapies by targeting cell-state plasticity using their AURIGIN™ AI platform.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
AI/ML infrastructure for drug discovery and target identification.
Single-cell genomics data analysis tools and platforms.
High-throughput screening systems.
Bioinformatics infrastructure for data analysis.
Advanced computational and molecular design approaches.
Service Requirements
Clinical trial design, planning, and execution services.
Regulatory consulting services.
Contract research organizations (CROs) for preclinical and clinical studies.
Clinical trial management systems.
Manufacturing capabilities for drug production.
Infrastructure Requirements
High-performance computing resources for AI/ML and genomic data processing.
Secure data storage and management solutions for sensitive patient data.
Infrastructure to support clinical trials and research activities.
Pharmaceutical Sciences laboratory.
Web server, browser software
Talent Requirements
Experienced clinical development professionals.
Data scientists with expertise in AI/ML and bioinformatics.
Pharmaceutical scientists with expertise in drug discovery and development.
Medical Directors/Senior Medical Directors.
Expertise in cancer biology, medicinal chemistry, and computational science.
AI Insights
Growth Trajectory
Auron Therapeutics' growth trajectory is strong, evidenced by their Series B financing completion, FDA clearance for AUTX-703 clinical development, and expansion into new therapeutic areas like autoimmune disease, indicating a high potential for future market expansion and innovation.
Market Opportunity
Auron Therapeutics has a significant market opportunity by focusing on cell-state plasticity and leveraging its AURIGIN™ platform to develop novel targeted cancer therapies, addressing the unmet needs of patients with solid tumor cancers and hematological malignancies.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats